New FDA standards on Covid-19 vaccine trials make approval by Election Day unlikely

To ensure delivery to your inbox add email@mail.nbcnews.com to your contacts | View in browser Add NBC News to your contacts Unsubscribe from this email

Oct 06, 2020 New FDA standards on Covid-19 vaccine trials make approval by Election Day unlikely The Food and Drug Administration said Tuesday that manufacturers of Covid-19 vaccines will need to follow tens of thousands of study participants for at least two months to look for any possible safety issues before the agency would consider authorization. The new guidance indicates that the earliest a Covid-19 vaccine might get an emergency use authorization would be the end of November — not Election Day, as President Donald Trump has previously asserted. Read More Get the NBC News Mobile App Follow NBC News Check out all of NBCNEWS Newsletters here. Update Preferences | Unsubscribe | Contact | Privacy Update Preferences Unsubscribe Contact Privacy